Jeanette Luke
Medical · Gilbert, AZNPI 1780318238
Payments from drug & device makers
Across 54 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$381
- AbbVie$216
- Lilly USA, LLC$85
- Amgen$69
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$67
- Vanda Pharmaceuticals Inc.$49
- plus $388 from 14 others
What the payments were for
- Food & beverage$1,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $381 |
| AbbVie | 14 | $216 |
| Lilly USA, LLC | 4 | $85 |
| Amgen | 4 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Phadia US Inc. | 2 | $46 |
| Exact Sciences | 2 | $46 |
| Novo Nordisk | 2 | $38 |
| Shield Therapeutics Inc | 1 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Gilead | 1 | $31 |
| GSK | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| Boehringer Ingelheim | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Boston Scientific | 1 | $17 |
| Abbott | 1 | $16 |
| Bayer | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$1,254 in reported general payments places this provider in the 60th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $937 |
| Cefdinir | 18 | $342 |
| Levothyroxine Sodium | 44 | $306 |
| Atorvastatin Calcium | 30 | $288 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $220 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $208 |
| Tamsulosin Hcl | 12 | $202 |
| Pantoprazole Sodium | 20 | $198 |
| Montelukast Sodium | 16 | $193 |
| Methocarbamol | 18 | $188 |
| Trazodone Hcl | 22 | $184 |
| Doxycycline Hyclate | 17 | $180 |
| Rosuvastatin Calcium | 15 | $158 |
| Losartan Potassium | 12 | $158 |
| Ciprofloxacin Hcl | 21 | $154 |
Paid to pharmacies, not to this prescriber.
Other medical in Gilbert
- Kevin MainGilbert$16K
- Ashley ConwayGilbert$13K
- Tiffany HaynieGilbert$13K
- Kristina ToddGilbert$11K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.